Company Plans U.S. Future for Cannabis Drug

LONDON (Reuters) - Britain's GW Pharmaceuticals said Monday it was accelerating plans to introduce its cannabis-based medicines into the United States as U.S. founder investors increased their stake in the business.

Continue to Company Plans U.S. Future for Cannabis Drug on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz